Derfor bør EVISTA først anvendes til behandling eller forebyggelse af osteoporose, når behandlingen af brystcancer inklusiv adjuverende behandling er tilendebragt.
Therefore, EVISTA should be used for osteoporosis treatment and prevention only after the treatment of breast cancer, including adjuvant therapy, has been completed.